Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02513225 · ClinicalTrials.gov registry record · NA
Trial of an Adapted STD Screening and Risk Reduction Intervention
A NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- NA
- Development phase
- 350
- Enrollment target
NCT02513225 is a NA study that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 350 participants.
The verdict
NCT02513225, a NA study, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
Study Summary
The goal of this research study is to evaluate the impact of a paraprofessional-delivered, culturally adapted, evidence-based intervention (EBI) on sexually transmitted disease (STD), substance use and poor mental/emotional health among American Indians (AI) through a Randomized Controlled Trial (RCT). These intertwining risks have produced marked disparities and have unique cultural and social determinants in Native communities. If aims are achieved, scientific knowledge and community-based practice will be advanced in areas vital to AI communities, and to STD and drug prevention science. Prior to this study, the investigators applied findings from research protocol (IRB#00005929) and adapted a brief intervention to reduce risk and increase protective behaviors for STDs, HIV/AIDS, substance use and poor mental/emotional health, and to promote STD screening. The specific aim of the current study is to compare the efficacy of the adapted brief intervention vs. a comparison condition on participants' condom use, STD screening and treatment-seeking behaviors, substance use and emotional/mental health outcomes at 3 and 6 months post-intervention.
Interventions
- BEHAVIORAL Project EMPWR
- OTHER Optimized Standard Care (OSC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2015-07 |
| Est. Completion | 2019-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02513225
The ClinicalTrials.gov registry entry for NCT02513225 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Project EMPWR is the first listed.
NCT02513225 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02513225 about?
NCT02513225 is a clinical study titled "Trial of an Adapted STD Screening and Risk Reduction Intervention". The goal of this research study is to evaluate the impact of a paraprofessional-delivered, culturally adapted, evidence-based intervention (EBI) on sexually transmitted disease (STD), substance use and poor mental/emotional health among American Indians (AI) through a Randomized Controlled Trial (RC...
What is the current status of trial NCT02513225?
This trial is currently completed. It is a NA study. The enrollment target is 350 participants. The study started on 2015-07. Estimated completion is 2019-07.
What interventions are being tested in trial NCT02513225?
The interventions under investigation include: Project EMPWR (BEHAVIORAL), Optimized Standard Care (OSC) (OTHER).
Who is sponsoring clinical trial NCT02513225?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.